Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1933864
Max Phase: Preclinical
Molecular Formula: C39H66N10O9S2
Molecular Weight: 883.15
Molecule Type: Small molecule
Associated Items:
ID: ALA1933864
Max Phase: Preclinical
Molecular Formula: C39H66N10O9S2
Molecular Weight: 883.15
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)C(S)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)O
Standard InChI: InChI=1S/C39H66N10O9S2/c1-22(2)20-29(38(57)58)48-35(54)28(16-19-60-5)45-34(53)26(14-9-10-17-40)47-37(56)31(24(4)50)49-32(51)23(3)44-33(52)27(15-11-18-43-39(41)42)46-36(55)30(59)21-25-12-7-6-8-13-25/h6-8,12-13,22-24,26-31,50,59H,9-11,14-21,40H2,1-5H3,(H,44,52)(H,45,53)(H,46,55)(H,47,56)(H,48,54)(H,49,51)(H,57,58)(H4,41,42,43)/t23-,24+,26-,27-,28-,29-,30?,31-/m0/s1
Standard InChI Key: DDQGCGHRLRYDLV-KIUURDKYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 883.15 | Molecular Weight (Monoisotopic): 882.4456 | AlogP: -0.89 | #Rotatable Bonds: 29 |
Polar Surface Area: 320.05 | Molecular Species: ZWITTERION | HBA: 12 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 19 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.99 | CX Basic pKa: 11.62 | CX LogP: -3.49 | CX LogD: -5.01 |
Aromatic Rings: 1 | Heavy Atoms: 60 | QED Weighted: 0.02 | Np Likeness Score: 0.12 |
1. Li B, Cardinale SC, Butler MM, Pai R, Nuss JE, Peet NP, Bavari S, Bowlin TL.. (2011) Time-dependent botulinum neurotoxin serotype A metalloprotease inhibitors., 19 (24): [PMID:22082667] [10.1016/j.bmc.2011.10.062] |
2. Zhou Y, McGillick BE, Teng YG, Haranahalli K, Ojima I, Swaminathan S, Rizzo RC.. (2016) Identification of small molecule inhibitors of botulinum neurotoxin serotype E via footprint similarity., 24 (20): [PMID:27543389] [10.1016/j.bmc.2016.07.031] |
Source(1):